Sabra Health Care REIT, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Sabra Health Care REIT, Inc. on March 20, 2025, with the earliest event reported on the same date. The filing addresses significant executive leadership changes and the execution of a post-employment consulting agreement.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to executive compensation under a new consulting arrangement:
- Annual Consulting Fee: $900,000
- Term: Two years (January 1, 2026, to December 31, 2027)
- Additional Compensation: Reimbursement of expenses and monthly cash payments covering medical benefits premiums.
Material Changes
The primary material change is the announced retirement of Talya Nevo-Hacohen, Executive Vice President, Chief Investment Officer, and Treasurer, effective December 31, 2025. Darrin Smith, currently Executive Vice President – Investments, is expected to assume the Chief Investment Officer role effective January 1, 2026.
Outlook, Risks, and Unusual Items
Management Commentary and Transition: Ms. Nevo-Hacohen will transition into a non-exclusive independent contractor role to assist in the handover of duties to Mr. Smith.
Equity Vesting: Unvested time-based and performance-based equity awards granted during her employment will continue to vest during the consulting term.
Change in Control: In the event of a change in control during the consulting term, Ms. Nevo-Hacohen is entitled to full acceleration of all outstanding equity awards.
Conditions: The agreement is contingent upon Ms. Nevo-Hacohen providing a valid, executed general release agreement in favor of the Company.
Key Facts for Investor Verification
- Confirm the exact effective date of Darrin Smith's assumption of the Chief Investment Officer title (January 1, 2026).
- Review the full text of the Consulting Agreement (Exhibit 10.1) for specific service obligations and termination clauses.
- Verify the status of Ms. Nevo-Hacohen's unvested equity awards and the specific terms regarding acceleration upon a change in control.
- Monitor future filings for any impact on the Company's liquidity or cash flow resulting from the $900,000 annual consulting fee.